These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 16374008

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chronic porcine two-hit model with hemorrhagic shock and Pseudomonas aeruginosa sepsis.
    Eissner B, Matz K, Smorodchenko A, Röschmann A, v Specht BU.
    Eur Surg Res; 2002; 34(1-2):61-7. PubMed ID: 11867903
    [Abstract] [Full Text] [Related]

  • 3. Immunization with outer membrane proteins (OprF and OprI) and flagellin B protects mice from pulmonary infection with mucoid and nonmucoid Pseudomonas aeruginosa.
    Hassan R, El-Naggar W, Abd El-Aziz AM, Shaaban M, Kenawy HI, Ali YM.
    J Microbiol Immunol Infect; 2018 Jun; 51(3):312-320. PubMed ID: 28291719
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A fusion protein vaccine containing OprF epitope 8, OprI, and type A and B flagellins promotes enhanced clearance of nonmucoid Pseudomonas aeruginosa.
    Weimer ET, Lu H, Kock ND, Wozniak DJ, Mizel SB.
    Infect Immun; 2009 Jun; 77(6):2356-66. PubMed ID: 19349426
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.
    Mansouri E, Blome-Eberwein S, Gabelsberger J, Germann G, von Specht BU.
    FEMS Immunol Med Microbiol; 2003 Jul 15; 37(2-3):161-6. PubMed ID: 12832120
    [Abstract] [Full Text] [Related]

  • 8. [Production of hybrid protein OprF-OprL of Pseudomonas aeruginosa].
    Kaloshin AA, Mikhaĭlova NA, Leonova EI.
    Zh Mikrobiol Epidemiol Immunobiol; 2012 Jul 15; (3):35-43. PubMed ID: 22830272
    [Abstract] [Full Text] [Related]

  • 9. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J, Knapp B, Bauersachs S, Enz UI, von Specht BU, Domdey H.
    Behring Inst Mitt; 1997 Feb 15; (98):302-14. PubMed ID: 9382754
    [Abstract] [Full Text] [Related]

  • 10. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B, Knapp B, Hungerer K, Lücking C, Schmitt A, Domdey H.
    J Biotechnol; 1996 Jan 26; 44(1-3):145-53. PubMed ID: 8717398
    [Abstract] [Full Text] [Related]

  • 11. Assessment of pulmonary antibodies with induced sputum and bronchoalveolar lavage induced by nasal vaccination against Pseudomonas aeruginosa: a clinical phase I/II study.
    Baumann U, Göcke K, Gewecke B, Freihorst J, von Specht BU.
    Respir Res; 2007 Aug 05; 8(1):57. PubMed ID: 17683588
    [Abstract] [Full Text] [Related]

  • 12. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A, Whu WZ, Xu Y, Joh J, Crystal RG, Worgall S.
    Vaccine; 2011 Mar 03; 29(11):2131-9. PubMed ID: 21215829
    [Abstract] [Full Text] [Related]

  • 13. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against Pseudomonas aeruginosa Infection.
    Norouzi F, Behrouz B, Ranjbar M, Mousavi Gargari SL.
    J Immunol Res; 2020 Mar 03; 2020():7840631. PubMed ID: 32566689
    [Abstract] [Full Text] [Related]

  • 14. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Mansouri E, Gabelsberger J, Knapp B, Hundt E, Lenz U, Hungerer KD, Gilleland HE, Staczek J, Domdey H, von Specht BU.
    Infect Immun; 1999 Mar 03; 67(3):1461-70. PubMed ID: 10024596
    [Abstract] [Full Text] [Related]

  • 15. Enhanced immunogenicity in the murine airway mucosa with an attenuated Salmonella live vaccine expressing OprF-OprI from Pseudomonas aeruginosa.
    Arnold H, Bumann D, Felies M, Gewecke B, Sörensen M, Gessner JE, Freihorst J, von Specht BU, Baumann U.
    Infect Immun; 2004 Nov 03; 72(11):6546-53. PubMed ID: 15501786
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Post-exposure immunization by capsid-modified AdC7 vector expressing Pseudomonas aeruginosa OprF clears P. aeruginosa respiratory infection.
    Gomi R, Sharma A, Wu W, Sung B, Worgall S.
    Vaccine; 2017 Dec 18; 35(51):7174-7180. PubMed ID: 29126807
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Therapeutic administration of anti-PcrV F(ab')(2) in sepsis associated with Pseudomonas aeruginosa.
    Shime N, Sawa T, Fujimoto J, Faure K, Allmond LR, Karaca T, Swanson BL, Spack EG, Wiener-Kronish JP.
    J Immunol; 2001 Nov 15; 167(10):5880-6. PubMed ID: 11698464
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.